Docetaxel and Prednisone with or without Lenalidomide in Chemotherapy-Naive Patients with Metastatic Castration-Resistant Prostate Cancer ( MAINSAIL ) : A Randomised , Double-Blind , Placebo-Controlled Phase 3 Trial

M. Moyad
Abstract:(Con nued on page 4) The use of aspirin a*er newly diagnosed nonmetasta c prostate cancer does not lower disease-specific or overall mortality, according to a large popula on-based study conducted in the United Kingdom. In fact, the risk for prostate cancer mortality increased in men who started aspirin therapy a*er diagnosis. The study was published in the April issue of the Journal of Urology.
What problem does this paper attempt to address?